H
RDY icon

Hexavest’s Dr. Reddy's Laboratories RDY Stock Holding History

Hexavest’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$222K Buy
+17,010
New +$227K 0.01% 201
2020
Q2 		– Sell
-13,515
Closed -$109K – 449
2020
Q1 		$109K Hold
13,515
– – ﹤0.01% 303
2019
Q4 		$110K Sell
13,515
-37,460
-73% -$296K ﹤0.01% 318
2019
Q3 		$386K Sell
50,975
-43,110
-46% -$321K 0.01% 255
2019
Q2 		$705K Sell
94,085
-45,775
-33% -$360K 0.01% 235
2019
Q1 		$1.13M Sell
139,860
-5,455
-4% -$41.4K 0.01% 211
2018
Q4 		$1.1M Sell
145,315
-32,855
-18% -$231K 0.02% 198
2018
Q3 		$1.23M Sell
178,170
-29,080
-14% -$194K 0.02% 200
2018
Q2 		$1.33M Sell
207,250
-688,540
-77% -$4.34M 0.02% 216
2018
Q1 		$5.86M Sell
895,790
-42,105
-4% -$295K 0.07% 175
2017
Q4 		$7.04M Buy
937,895
+567,735
+153% +$4.09M 0.08% 187
2017
Q3 		$2.64M Buy
370,160
+282,610
+323% +$2.03M 0.03% 220
2017
Q2 		$738K Buy
87,550
+76,760
+711% +$624K 0.01% 253
2017
Q1 		$87K Buy
10,790
+630
+6% +$5.44K ﹤0.01% 371
2016
Q4 		$92K Buy
10,160
+5,605
+123% +$52.2K ﹤0.01% 358
2016
Q3 		$42K Buy
4,555
+1,185
+35% +$11.3K ﹤0.01% 399
2016
Q2 		$35K Hold
3,370
– – ﹤0.01% 417
2016
Q1 		$30K Hold
3,370
– – ﹤0.01% 414
2015
Q4 		$31K Hold
3,370
– – ﹤0.01% 410
2015
Q3 		$43K Hold
3,370
– – ﹤0.01% 385
2015
Q2 		$37K Sell
3,370
-3,630
-52% -$40.1K ﹤0.01% 401
2015
Q1 		$80K Sell
7,000
-4,965
-41% -$52.7K ﹤0.01% 351
2014
Q4 		$121K Sell
11,965
-237,830
-95% -$2.5M ﹤0.01% 295
2014
Q3 		$2.63M Sell
249,795
-47,190
-16% -$444K 0.04% 210
2014
Q2 		$2.56M Buy
296,985
+55,855
+23% +$470K 0.04% 210
2014
Q1 		$2.12M Sell
241,130
-250,085
-51% -$2.18M 0.03% 208
2013
Q4 		$4.03M Buy
491,215
+3,930
+0.8% +$31.1K 0.06% 187
2013
Q3 		$3.68M Buy
487,285
+212,000
+77% +$1.54M 0.06% 201
2013
Q2 		$2.08M Buy
+275,285
New +$2.01M 0.04% 208

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Hexavest's RDY Position: Q3 2021 in Review

Hexavest opened a new position in Dr. Reddy's Laboratories (RDY) in Q3 2021: 17,010 shares worth $222K. The stake represents 0.01% of the portfolio and ranks #201 among its holdings. This is a return to the name: Hexavest previously reported a position in RDY as recently as Q1 2020.

Hexavest first reported a position in RDY in Q2 2013 and has held it in 29 quarters since. The position peaked at $7.04M in Q4 2017. 149 funds tracked by Wall St. Rank hold RDY as of Q3 2021.

  • Hexavest held 17,010 shares of Dr. Reddy's Laboratories worth $222K as of Q3 2021.
  • Dr. Reddy's Laboratories was a new Hexavest position in Q3 2021.
  • Dr. Reddy's Laboratories made up 0.01% of Hexavest's portfolio in Q3 2021, its #201 holding.
  • Hexavest first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 29 quarters since.
  • Hexavest's Dr. Reddy's Laboratories position peaked at $7.04M in Q4 2017.
  • 149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2021.

Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.